iShares IBB ETF: Biotech M&As Are Back! (NASDAQ:IBB)
monstArrr_/iStock via Getty Images The US biotechnology sector has been an absolute loser so far in 2022. S&P Biotechnology index is down 60% from its 2021 highs. The investment community remains concerned about inflationary pressures […]
